Related Experiment Video

Updated: Sep 27, 2025

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Published on: December 19, 2019

14.7K

Impact of Cannabinoid Compounds on Skin Cancer

Robert Ramer1, Franziska Wendt1, Felix Wittig1

  • 1Institute of Pharmacology and Toxicology, Rostock University Medical Centre, 18057 Rostock, Germany.

Cancers
|April 12, 2022
PubMed

Insights

Cannabinoid compounds show promise for treating skin cancers like melanoma and squamous cell carcinoma. These compounds target the endocannabinoid system to inhibit tumor growth and induce cancer cell death.

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • The endocannabinoid system plays a role in skin homeostasis.
  • Cannabinoid compounds have shown potential in preclinical cancer models.
  • Emerging research suggests cannabinoids' utility in skin cancer treatment and prevention.

Purpose of the Study:

  • To review the current literature on cannabinoid compounds for skin cancer treatment.
  • To explore the potential of cannabinoids in treating melanoma and squamous cell carcinoma.
  • To summarize the anticarcinogenic mechanisms of cannabinoids in skin cancer.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of research on cannabinoid compounds and skin cancer.
  • Synthesis of findings on cannabinoid mechanisms of action.

Main Results:

  • Cannabinoids demonstrate anticarcinogenic effects at various stages of skin cancer progression.
  • Observed effects include inhibition of tumor growth, proliferation, invasion, and angiogenesis.
  • Cannabinoids have been shown to induce apoptosis and autophagy in cancer cells.

Conclusions:

  • Cannabinoid compounds are promising candidates for melanoma and squamous cell carcinoma therapy.
  • The endocannabinoid system is a viable target for novel skin cancer treatments.
  • Further research into cannabinoid-based pharmaceuticals for skin cancer is warranted.
Keywords:
cannabinoidsendocannabinoid systemmelanomaskin cancersquamous cell carcinoma

More Related Videos

Studying Chronic Exposure of Mice to Ultraviolet B Radiation03:20

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

1.2K
Cell Population Analyses During Skin Carcinogenesis06:53

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

12.6K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.8K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
379
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.4K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K